Rigel Pharmaceuticals
RIGL
#6818
Rank
S$0.95 B
Marketcap
S$50.76
Share price
-13.26%
Change (1 day)
12.91%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): S-$0.30

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$22.62. In 2022 the company made an earnings per share (EPS) of S-$0.44 a decrease over its 2021 EPS that were of S-$0.13.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.30-29.94%
2022S-$0.44240%
2021S-$0.13-37.5%
2020S-$0.20-60%
2019S-$0.51-11.11%
2018S-$0.58-26.23%
2017S-$0.78-17.57%
2016S-$0.9525.42%
2015S-$0.76-42.72%
2014S-$1.321.98%
2013S-$1.29-24.06%
2012S-$1.70-4.32%
2011S-$1.78-290.41%
2010S$0.93-126.64%
2009S-$3.51-25.14%
2008S-$4.6941.86%
2007S-$3.3070.86%
2006S-$1.93-27.4%
2005S-$2.66-33.33%
2004S-$3.99-37.73%
2003S-$6.41-31.83%
2002S-$9.41-63.55%
2001S-$25.81-96.43%
2000S-$723.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$20.77-8.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.55-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
S-$0.49-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
S-$2.42-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA